Richard J. Rodgers

Insider Reports History

Location
C/O Tesaro, Inc., 1000 Winter St., Ste 3300, Waltham, MA
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard J. Rodgers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Director Common Stock 414K $1.5M $3.62 Jun 18, 2025 Direct
Opus Genetics, Inc. Director Common Stock 319K $284K $0.89 Apr 30, 2025 Direct
NOVAVAX INC Director Stock Option (Right to Buy) 28.3K $182K $6.42 Jun 20, 2025 Direct
NOVAVAX INC Director Common Stock 24.7K $153K $6.19 Jun 12, 2025 Direct
NOVAVAX INC Director Restricted Stock Units 18.9K $30.4K $8.00 Jun 20, 2025 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54.1K $0 $2.32 Jun 18, 2025 Direct
Opus Genetics, Inc. Director Stock Option (Right to Buy) 79.6K Apr 30, 2025 Direct
Sagimet Biosciences Inc. Director Stock Option (Right to Buy) 23.8K Jul 18, 2023 Direct

Insider Reports Filed by Richard J. Rodgers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Jun 20, 2025 2 $182K 4 Jun 24, 2025 Director
ARDX ARDELYX, INC. Jun 18, 2025 3 $0 4 Jun 23, 2025 Director
NVAX NOVAVAX INC Jun 12, 2025 2 $0 4 Jun 13, 2025 Director
IRD Opus Genetics, Inc. Apr 30, 2025 2 $0 4 May 2, 2025 Director
ARDX ARDELYX, INC. Jan 16, 2025 2 $55K 4 Jan 17, 2025 Director
NVAX NOVAVAX INC Oct 29, 2024 2 $0 4 Jan 2, 2025 Director
ARDX ARDELYX, INC. Jun 14, 2024 2 $0 4 Jun 17, 2024 Director
NVAX NOVAVAX INC Jun 12, 2024 4 $248K 4 Jun 14, 2024 Director
OCUP Ocuphire Pharma, Inc. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
OCUP Ocuphire Pharma, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
OCUP Ocuphire Pharma, Inc. Nov 1, 2023 1 $0 4 Nov 13, 2023 Director
NVAX NOVAVAX INC Oct 29, 2023 2 $0 4 Oct 31, 2023 Director
SGMT Sagimet Biosciences Inc. Jul 18, 2023 6 $0 4 Jul 20, 2023 Director
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 Director
ARDX ARDELYX, INC. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
NVAX NOVAVAX INC Jun 12, 2023 2 $0 4 Jun 13, 2023 Director
OCUP Ocuphire Pharma, Inc. Apr 19, 2023 1 $0 4 Apr 21, 2023 Interim CEO and President, Director
OCUP Ocuphire Pharma, Inc. Jan 11, 2023 1 $0 4 Jan 12, 2023 Director
NVAX NOVAVAX INC Oct 29, 2022 2 $0 4 Nov 1, 2022 Director
NVAX NOVAVAX INC Oct 29, 2022 0 $0 3 Nov 1, 2022 Director
OCUP Ocuphire Pharma, Inc. Oct 3, 2022 2 $0.32 4 Oct 4, 2022 Director
OCUP Ocuphire Pharma, Inc. Jul 1, 2022 2 $0 4 Jul 6, 2022 Director
ARDX ARDELYX, INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
OCUP Ocuphire Pharma, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
OCUP Ocuphire Pharma, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
OCUP Ocuphire Pharma, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
OCUP Ocuphire Pharma, Inc. Oct 1, 2021 1 $0 4 Oct 4, 2021 Director
OCUP Ocuphire Pharma, Inc. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
ARDX ARDELYX, INC. Jun 16, 2021 2 $0 4 Jun 21, 2021 Director
OCUP Ocuphire Pharma, Inc. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director